Z-1513-2014 Class II Terminated
FDA device recall Z-1513-2014 was initiated by Brainlab AG on Feb 24, 2014 and is designated Class II. Reason for recall: When using multiple radiation treatment targets within a single plan, the ExacTrac v.6.0.3 might position the patient to an unintended radiation treatment point. As a result, there is a possibility… The recall status is terminated (terminated Apr 24, 2017). Affected quantity: 41 systems (13 systems in US; 28 systems to foreign countries).
Recall details
- Product Type
- Devices
- Report Date
- May 7, 2014
- Initiation Date
- Feb 24, 2014
- Termination Date
- Apr 24, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 41 systems (13 systems in US; 28 systems to foreign countries)
Product description
Reason for recall
Distribution pattern
Worldwide Distribution -- USA, including the states of CA, IN, LA, MA, OH, TX, and WI, and the countries of Australia, China, France, Germany, Japan, Netherlands, and the United Kingdom.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1513-2014
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Brainlab AG? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.